Engineering Bacteria and Bionic Bacterial Derivatives with Nanoparticles for Cancer Therapy
Abstract
Natural bacteria are interesting subjects for cancer treatments owing to their unique autonomy‐driven and hypoxic target properties. Genetically modified bacteria (such as bacteria with msbB gene and aroA gene modifications) can effectively cross sophisticated physiological barriers and transport antitumor agents into deep tumor tissues, and they have good biosafety. Additionally, bacteria can secrete cytokines (such as interleukin‐224, interferon‐gamma [IFN‐γ], and interleukin‐1β) and activate antitumor immune responses in the tumor microenvironment, resulting in tumor inhibition. All of these characteristics can be easily utilized to develop synergistic antitumor strategies by combining bacteria‐based agents with other therapeutic approaches. Herein, representative studies of bacteria‐instructed multimodal synergistic cancer therapy are introduced (e.g., photothermal therapy, chemoimmunotherapy, photodynamic therapy, and photocontrolled bacterial metabolite therapy), and their key advantages are systematically expounded. The current challenges and future prospects in advancing the development of bacteria‐based micro/nanomedicines in the field of synthetic biology research are also emphasized, which will hopefully promote the development of related bacteria‐based cancer therapies.Keywords
Funding Information
- National Natural Science Foundation of China (81901864, 21701033)
- Natural Science Foundation of Guangdong Province (2019A1515011524, 2021A1515010131)
This publication has 81 references indexed in Scilit:
- Gold Nanoparticle Imaging and Radiotherapy of Brain Tumors in MiceNanomedicine, 2013
- Nontoxic radioactive Listeria at is a highly effective therapy against metastatic pancreatic cancerProceedings of the National Academy of Sciences, 2013
- Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-TargetingSalmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma TumorsCancer Research, 2011
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- In Vivo Synthesis of Diverse Metal Nanoparticles by Recombinant Escherichia coliAngewandte Chemie International Edition, 2010
- Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent miceBioengineered Bugs, 2010
- Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containmentProceedings of the National Academy of Sciences, 2008
- The thermal impulse response of Escherichia coliProceedings of the National Academy of Sciences, 2008
- AttenuatedSalmonellaengineered to produce human cytokine LIGHT inhibit tumor growthProceedings of the National Academy of Sciences, 2007
- Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumoursEuropean Journal of Cancer, 2007